Live feed
Filing
SC 13G/A
SC 13G/A0000902664-19-000474·BioPharmX Corp
Schedule 13G ownership disclosure
Biopharmx
Security class unavailable · CUSIP: 09072X101
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 7,858,659
- Percent of class
- 8.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-19-000474
- Form type
- SC 13G/A
- Filer
- BioPharmX Corp
- CIK
- CIK 1504167
- Filed
- Jan 29, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership